Silicon Laboratories Valuation

SLAB Stock  USD 204.24  0.11  0.05%   
At this time, the company appears to be undervalued. Silicon Laboratories has a current Real Value of $220.6 per share. The regular price of the company is $204.24. Our model measures the value of Silicon Laboratories from inspecting the company fundamentals such as Return On Equity of -0.0597, operating margin of (0.02) %, and Shares Outstanding of 32.96 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Silicon Laboratories' valuation include:
Price Book
4.1296
Enterprise Value
B
Enterprise Value Ebitda
79.2361
Price Sales
8.5814
Forward PE
56.8182
Undervalued
Today
204.24
Please note that Silicon Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Silicon Laboratories is based on 3 months time horizon. Increasing Silicon Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Silicon Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Silicon Stock. However, Silicon Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  204.24 Real  220.6 Target  222.86 Hype  205.03 Naive  195.15
The real value of Silicon Stock, also known as its intrinsic value, is the underlying worth of Silicon Laboratories Company, which is reflected in its stock price. It is based on Silicon Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Silicon Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
183.92
Downside
220.60
Real Value
227.34
Upside
Estimating the potential upside or downside of Silicon Laboratories helps investors to forecast how Silicon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Silicon Laboratories more accurately as focusing exclusively on Silicon Laboratories' fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
0.590.660.75
Details
Hype
Prediction
LowEstimatedHigh
198.29205.03211.77
Details
Naive
Forecast
LowNext ValueHigh
188.41195.15201.90
Details
11 Analysts
Consensus
LowTarget PriceHigh
202.80222.86247.37
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Silicon Laboratories' intrinsic value based on its ongoing forecasts of Silicon Laboratories' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Silicon Laboratories' closest peers. If more than one evaluation category is relevant for Silicon Laboratories we suggest using both methods to arrive at a better estimate.

Silicon Laboratories Cash

232.31 Million

Silicon Laboratories Total Value Analysis

Silicon Laboratories is at this time forecasted to have valuation of 4.02 B with market capitalization of 6.73 B, debt of 174.9 M, and cash on hands of 364.22 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Silicon Laboratories fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
4.02 B
6.73 B
174.9 M
364.22 M

Silicon Laboratories Investor Information

About 98.0% of the company shares are owned by institutional investors. The book value of Silicon Laboratories was at this time reported as 33.21. The company has Price/Earnings (P/E) ratio of 260.36. Silicon Laboratories recorded a loss per share of 1.98. The entity had not issued any dividends in recent years. Based on the key indicators related to Silicon Laboratories' liquidity, profitability, solvency, and operating efficiency, Silicon Laboratories is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in March.

Silicon Laboratories Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Silicon Laboratories has an asset utilization ratio of 61.83 percent. This suggests that the Company is making $0.62 for each dollar of assets. An increasing asset utilization means that Silicon Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Silicon Laboratories Profitability Analysis

Based on Silicon Laboratories' profitability indicators, Silicon Laboratories is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in March. Profitability indicators assess Silicon Laboratories' ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2000-03-31
Previous Quarter
-9.9 M
Current Value
-2.7 M
Quarterly Volatility
205.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
At present, Silicon Laboratories' Pretax Profit Margin is projected to slightly decrease based on the last few years of reporting. The current year's Operating Profit Margin is expected to grow to 0.12, whereas Gross Profit is forecasted to decline to about 335.6 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.630.5823
Significantly Up
Very volatile
For Silicon Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Silicon Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Silicon Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Silicon Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Silicon Laboratories over time as well as its relative position and ranking within its peers.

Silicon Laboratories Earnings per Share Projection vs Actual

The next projected EPS of Silicon Laboratories is estimated to be 0.6598 with future projections ranging from a low of 0.59 to a high of 0.75. Silicon Laboratories' most recent 12-month trailing earnings per share (EPS TTM) is at -1.98. Please be aware that the consensus of earnings estimates for Silicon Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Silicon Laboratories is projected to generate 0.6598 in earnings per share on the 30th of June 2026. Silicon Laboratories earnings estimates show analyst consensus about projected Silicon Laboratories EPS (Earning Per Share). It derives the highest and the lowest estimates based on Silicon Laboratories' historical volatility. Many public companies, such as Silicon Laboratories, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Silicon Laboratories Earnings Estimation Breakdown

The calculation of Silicon Laboratories' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Silicon Laboratories is estimated to be 0.6598 with the future projection ranging from a low of 0.59 to a high of 0.75. Please be aware that this consensus of annual earnings estimates for Silicon Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
0.59
Lowest
Expected EPS
0.6598
0.75
Highest

Silicon Laboratories Earnings Projection Consensus

Suppose the current estimates of Silicon Laboratories' value are higher than the current market price of the Silicon Laboratories stock. In this case, investors may conclude that Silicon Laboratories is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Silicon Laboratories' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2026Current EPS (TTM)
1184.18%
0.0
0.6598
-1.98

Silicon Laboratories Ownership Allocation

The majority of Silicon Laboratories outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Silicon Laboratories to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Silicon Laboratories. Please pay attention to any change in the institutional holdings of Silicon Laboratories as this could imply that something significant has changed or is about to change at the company.

Silicon Laboratories Profitability Analysis

The company reported the previous year's revenue of 784.76 M. Net Loss for the year was (64.91 M) with profit before overhead, payroll, taxes, and interest of 456.98 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Silicon Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Silicon Laboratories and how it compares across the competition.

About Silicon Laboratories Valuation

The stock valuation mechanism determines Silicon Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Silicon Laboratories. We calculate exposure to Silicon Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Silicon Laboratories's related companies.
Last ReportedProjected for Next Year
Gross Profit457 M335.6 M
Pretax Profit Margin(0.07) 0.13 
Operating Profit Margin(0.09) 0.12 
Net Profit Margin(0.08) 0.09 
Gross Profit Margin 0.58  0.63 

Silicon Laboratories Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding32.7 M
Quarterly Earnings Growth Y O Y-0.467
Forward Price Earnings56.8182

Silicon Laboratories Current Valuation Indicators

Valuation refers to the process of determining the present value of Silicon Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Silicon we look at many different elements of the entity such as Silicon's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Silicon Laboratories, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Silicon Laboratories' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Silicon Laboratories' worth.

Complementary Tools for Silicon Stock analysis

When running Silicon Laboratories' price analysis, check to measure Silicon Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silicon Laboratories is operating at the current time. Most of Silicon Laboratories' value examination focuses on studying past and present price action to predict the probability of Silicon Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silicon Laboratories' price. Additionally, you may evaluate how the addition of Silicon Laboratories to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements